These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7147991)

  • 1. Metabolism and excretion of the liver-protective agent (+)-catechin in experimental hepatitis.
    Shaw IC; Hackett AM; Griffiths LA
    Xenobiotica; 1982 Jul; 12(7):405-16. PubMed ID: 7147991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of an experimental hepatitis on the metabolic disposition of 3-o-(+)-[14C]methylcatechin in the rat.
    Hackett AM; Griffiths LA
    Drug Metab Dispos; 1983; 11(6):602-6. PubMed ID: 6140147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prevention by (+)-Cyanidanol-3 of hepatitis-induced changes in the disposition of imipramine in the rat.
    Hackett AM; Shaw IC; Griffiths LA
    Biochem Pharmacol; 1984 Jul; 33(14):2179-84. PubMed ID: 6466342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The metabolism and excretion of 3-palmitoyl-(+)-catechin in the rat.
    Hackett AM; Griffiths LA
    Xenobiotica; 1982 Jul; 12(7):447-56. PubMed ID: 6815903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The metabolism and excretion of [14C]imipramine in an experimental hepatitis.
    Hackett AM; Shaw IC; Griffiths LA
    Xenobiotica; 1984 Jun; 14(6):491-9. PubMed ID: 6475108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the major biliary metabolite of (+)-catechin in the rat.
    Shaw IC; Griffiths LA
    Xenobiotica; 1980 Dec; 10(12):905-11. PubMed ID: 7210703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The metabolism and excretion of 3-O-methyl-(+)-catechin in the rat, mouse, and marmoset.
    Hackett AM; Griffiths LA
    Drug Metab Dispos; 1981; 9(1):54-9. PubMed ID: 6111433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The disposition of 3-O-methyl-(+)-catechin in the rat and the marmoset following oral administration.
    Hackett AM; Griffiths LA
    Eur J Drug Metab Pharmacokinet; 1983; 8(1):35-42. PubMed ID: 6407839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The quantitative disposition of 3-O-methyl-(+)-[U-14C]catechin in man following oral administration.
    Hackett AM; Griffiths LA; Wermeille M
    Xenobiotica; 1985 Nov; 15(11):907-14. PubMed ID: 4082631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on flavonoid metabolism. Biliary and urinary excretion of metabolites of (+)-(U- 14 C)catechin.
    Das NP; Sothy SP
    Biochem J; 1971 Nov; 125(2):417-23. PubMed ID: 5144742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catechin is metabolized by both the small intestine and liver of rats.
    Donovan JL; Crespy V; Manach C; Morand C; Besson C; Scalbert A; Rémésy C
    J Nutr; 2001 Jun; 131(6):1753-7. PubMed ID: 11385063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of galactosamine-induced hepatic UDP-glucuronic acid depletion on acetaminophen elimination in rats. Dispositional differences between hepatically and extrahepatically formed glucuronides of acetaminophen and other chemicals.
    Gregus Z; Madhu C; Goon D; Klaassen CD
    Drug Metab Dispos; 1988; 16(4):527-33. PubMed ID: 2903018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism of (+)-catechin and some of its C-6 and C-8 substituted derivatives in the isolated perfused pig liver.
    van der Merwe PJ; Hundt HK
    Xenobiotica; 1984 Oct; 14(10):795-802. PubMed ID: 6506752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of liquiritigenin and its two glucuronides, M1 and M2, in rats with acute hepatitis induced by d-galactosamine/lipopolysaccharide or CCl(4).
    Kang HE; Kim YW; Sohn SI; Baek SR; Lee JW; Kim SG; Lee I; Lee MG
    Xenobiotica; 2010 Jun; 40(6):424-36. PubMed ID: 20350053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flavonoids and hepatic cyclic monophosphates in liver injury.
    Scevola D; Barbarini G; Grosso A; Bona S; Perissoud D
    Boll Ist Sieroter Milan; 1984 Mar; 63(1):77-82. PubMed ID: 6089850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of microsomal enzyme inducers on biliary and urinary excretion of acetaminophen metabolites in rats. Decreased hepatobiliary and increased hepatovascular transport of acetaminophen-glucuronide after microsomal enzyme induction.
    Gregus Z; Madhu C; Klaassen CD
    Drug Metab Dispos; 1990; 18(1):10-9. PubMed ID: 1970767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative transport pathways of cholephilic 14C-hexobarbital metabolites in rats with experimental hepatitis and cholestasis.
    Richter E; Joeres R; Buschmann J; Zilly W
    Acta Hepatogastroenterol (Stuttg); 1979 Dec; 26(6):429-34. PubMed ID: 549423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of silymarin (Carsil) on the microsomal glycoprotein and protein biosynthesis in liver of rats with experimental galactosamine hepatitis.
    Tyutyulkova N; Gorantcheva U; Tuneva S; Chelibonova-Lorer H; Gavasova E; Zhivkov V
    Methods Find Exp Clin Pharmacol; 1983; 5(3):181-4. PubMed ID: 6888084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The metabolism and excretion of (+)-[14C]cyanidanol-3 in man following oral administration.
    Hackett AM; Griffiths LA; Broillet A; Wermeille M
    Xenobiotica; 1983 May; 13(5):279-86. PubMed ID: 6636824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatobiliary clearance of labelled mebrofenin in normal and D-galactosamine HCl-induced hepatitis rats and the protective effect of turmeric extract.
    Deshpande UR; Joseph LJ; Samuel AM
    Indian J Physiol Pharmacol; 2003 Jul; 47(3):332-6. PubMed ID: 14723320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.